Dr. Marilena Vlachou is an Associate Professor at the
National and Kapodistrian University of Athens (NKUA), Greece. She obtained her
B.Pharm and Ph.D. (Pharmaceutical Technology) degrees from the NKUA. Just
before obtaining her Ph.D., she moved to the University of Rhode Island, United
States, as a Visiting Research Scientist to conduct cutting-edge research on
Pharmaceutical Technology techniques. Her research interests include the formulation
and in vitro release of bioactive substances from topical formulations, the
efficacy and safety of formulations in skin disease therapies, the modified
release of novel synthetic bioactive molecules, with diverse activity, the
investigation of the physicochemical properties of new excipients, including
those of marine origin (Ulvans), and nanomaterials, concerning their
interaction with active pharmaceutical ingredients (APIs), 3D/4D printlets and
AI-based pharmaceutical formulations’ development. Dr. Vlachou is a member of
various scientific societies, including the Royal Society of Medicine, London,
has published more than 75 research articles in peer-reviewed journals, and has
been an invited speaker at many scientific conferences/symposiums.
Research Keywords & Expertise
Drug Delivery
PHARMACEUTICAL TECHNOL...
drug release
modified release
physical pharmacy
Fingerprints
33%
modified release
25%
Drug Delivery
18%
drug release
Short Biography
Dr. Marilena Vlachou is an Associate Professor at the
National and Kapodistrian University of Athens (NKUA), Greece. She obtained her
B.Pharm and Ph.D. (Pharmaceutical Technology) degrees from the NKUA. Just
before obtaining her Ph.D., she moved to the University of Rhode Island, United
States, as a Visiting Research Scientist to conduct cutting-edge research on
Pharmaceutical Technology techniques. Her research interests include the formulation
and in vitro release of bioactive substances from topical formulations, the
efficacy and safety of formulations in skin disease therapies, the modified
release of novel synthetic bioactive molecules, with diverse activity, the
investigation of the physicochemical properties of new excipients, including
those of marine origin (Ulvans), and nanomaterials, concerning their
interaction with active pharmaceutical ingredients (APIs), 3D/4D printlets and
AI-based pharmaceutical formulations’ development. Dr. Vlachou is a member of
various scientific societies, including the Royal Society of Medicine, London,
has published more than 75 research articles in peer-reviewed journals, and has
been an invited speaker at many scientific conferences/symposiums.